GlassScriptPhysician profile
Benjamin J Averkamp
NPI 1043848096
$10,213.55
in general payments reported to CMS, 2019-2025
13 companies · $1,154 in 2025
The $1,154 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,241 · 2021: $1,992 · 2022: $4,987 · 2023: $361 · 2024: $478 · 2025: $1,154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,993.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,992.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Peerless Surgical INC. | $7,722.64 | 2020-2025 | |
| Stryker Corporation | $1,399.15 | 2021-2025 | Citrefix, 7 X 23mm Citrelock Implant, 1788 |
| Depuy Synthes Sales INC. | $316.70 | 2025 | Motoband, Vivigen Mis Delivery System, Hammerlock |
| Integra Lifesciences Corporation | $253.99 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Davol INC. | $136.11 | 2024 | Arista Ah Flexitip |
| Arthrex, INC. | $124.89 | 2021-2025 | |
| Skeletal Dynamics INC | $117.17 | 2025 | Ijs, Geminus, Implate |
| Paragon 28, INC. | $38.55 | 2023 | Portfolio |
| Heraeus Medical, LLC. | $36.70 | 2022-2023 | Palacos |
| Onkos Surgical, INC. | $24.01 | 2020 | |
| Treace Medical Concepts, INC. | $14.93 | 2024 | |
| Endo Pharmaceuticals INC. | $14.69 | 2021 | |
| Bioventus LLC | $14.02 | 2023 | Durolane |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Averkamp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.